Biomerica launches gastrointestinal disease test:
This article was originally published in Clinica
Biomerica has added to its line of gastrointestinal disease tests with the launch of Pepgen, an ELISA-based test for pepsinogen-I in plasma. Pepsinogen-I is a precursor of the proteolytic enzyme pepsin. Its concentration in plasma is elevated in patients with peptic ulcers, but depressed in patients with gastric cancer. The new test, which can be used in small laboratories with minimal equipment or automated on a laboratory analyser, can thus be used to distinguish between the two conditions. It is available through Biomerica's distributor network in over 40 countries.